tykhr
sign in
free sign up
Grifols SA ADR
Drug Manufacturers - General
Healthcare
GRFS
689 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.91
52 week high
10.85
high
10.05
52 week low
0.00
low
9.82
growth
10.06 %
previous Close
9.70
P/E ratio
market cap
9.18 B
div yield
0
usd
Jun 2025
qoq
revenue
1.89 B
0.00 %
net incoming
117 M
0.00 %
eps
0.00 %
141.34 %
eps surprise
-0.04 %
net profit margin
6.19 %
6.00 %
operating incoming
349 M
0.00 %
net change in cash
0.00 %
cash on hand
559 M
0.00 %
cost of revenue
1.15 B
0.00 %
top